Effects of ACE inhibitors versus calcium antagonists on left ventricular morphology and function in patients with essential hypertension

Hypertension Research

Volumn 20, Issue 1, 1997, Pages 7-10

  Matsuzaki, Keisuke ^a   Mukai, Mikio ^a   Sumimoto, Takumi ^a   Murakami, Eiki ^a  

^a Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

Author keywords

ACE inhibitors; Ca antagonists; Hypertension; Left ventricular function; Left ventricular hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; CERANAPRIL; DELAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NICARDIPINE; NIFEDIPINE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; LONG TERM CARE; MALE; MEAN ARTERIAL PRESSURE; MORPHOLOGY; RANDOMIZED CONTROLLED TRIAL; RELAXATION TIME; SYSTOLIC TIME INTERVAL;

EID: 0030895501     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.20.7     Document Type: Article

References (17)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implication of echocardiographically determined left ventricular mass in the Framingam Heart Study. N Engl J Med 1990; 322: 1561-1566.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Left ventricular mass and incidence of coronary heart disease in an elderly cohort: The Framingam Heart Study. Ann Intern Med 1989; 110: 101-107.
3. Cruickshank JM, Lewis J, Moore V, Dodd C: Reversibility of left ventricular hypertrophy by differing type of antihypertensive therapy. J Hum Hypertens 1992; 6: 85-90.
4. Dahlöf B, Pennert K, Hansson L:. Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-110.
5. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
6. Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy finding. Am J Cardiol 1986; 57: 450-458.
7. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensinaldosterone system. Circulation 1991; 83: 1849-1865.
8. Lund DD, Twitmeyer AT, Schmid PG, Tomanek RJ: Independent changes in cardiac muscle fibers and connective tissue in rats with spontaneous hypertension, aortic constriction and hypoxia. Cardiovasc Res 1979; 13: 39-44.
9. Brilla CG, Weber KT: Mineralocorticoid excess, dietary sodium and mydcardial fibrosis. J Lab Clin Med 1992; 120: 893-901.
10. Brilla CG, Janicki JS, Weber KT: Impaired diastolic function and coronary reserve in genetic hyperension: role of interstitial fibrosis and media thickening of intramyocardial coronary arteries. Circ Res 1991; 69: 107-115.
11. Motz W, Strauer BE: Left ventricular function and collagen content after regression of hypertensive hypertrophy. Hypertension 1989; 13: 43-50.
12. Susie D, Frohlich ED: Left ventricular hypertrophy: a pathophysiological and molecular biological perspective. Hypertens Res 1993; 16: 163-177.
13. Brutsaert DL, Rademakers FE, Sys SU: Triple control of relaxation: implication in cardiac disease. Circulation 1984; 69: 190-196.
14. Morgan JP, Morgan KJ: Calcium and cardiovascular function: intracellular calcium levels during contraction and relaxation of mammalian cardiac and vascular smooth muscle as detected by aequorin. Am J Med 1984; 77 (Suppl 5A): 33-36.
15. Glantz SA, Parmley WW: Factors which affect the diastolic pressure-volume curve. Circ Res 1978; 42: 171-178.
16. Betocchi S, Chiariello M: Effects of calcium antagonists on left ventricular structure and function. J Hypertens 1993; 11(Suppl 1): 533-537.
17. Eselin JA, Carter BL: Hypertension and left ventricular hypertrophy: Is drug therapy beneficial? Pharmacotherapy 1994; 14(1): 60-88.